Clinical trial
A Research Study for Patients With Prostate Cancer
NCT00106418 · Celgene, Industry · Completed
Key facts
| NCT number | NCT00106418 |
|---|---|
| Title | A Research Study for Patients With Prostate Cancer |
| Official title | An Exploratory Phase II, Multicenter, Open-label Trial Evaluating the Activity and Tolerability of FK228 in Androgen Independent Metastatic Prostate Cancer Patients With Rising PSA |
| Lead sponsor | Celgene, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer, Metastases |
| Intervention type | Drug |
| Interventions | Romidepsin |
| Enrollment | 35 |
| Start date | May 7, 2003 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Mar 25, 2005 |
| Last update posted | Nov 18, 2019 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: